Detalhe da pesquisa
1.
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE).
Cancer
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340349
2.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161051
3.
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin
; 67(3): 245-253, 2017 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222223
4.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
5.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(10): 1094-1108, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37714168
6.
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.
Prostate
; 83(11): 1028-1034, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37113064
7.
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancer.
Prostate
; 83(9): 879-885, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959766
8.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382533
9.
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet
; 399(10338): 1886-1901, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569466
10.
PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials.
Oncologist
; 28(5): 392-401, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806966
11.
The Value of Phenotypic Precision Medicine in Prostate Cancer.
Oncologist
; 28(2): 93-104, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200788
12.
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab.
Oncologist
; 28(3): 276-e158, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210487
13.
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 383(24): 2345-2357, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955174
14.
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 382(22): 2091-2102, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343890
15.
Targeted Alpha-Particle Therapy: A Review of Current Trials.
Int J Mol Sci
; 24(14)2023 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511386
16.
Immune mechanisms behind prostate cancer in men of African ancestry: A review.
Prostate
; 82(8): 883-893, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254710
17.
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Prostate
; 82(12): 1202-1209, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652618
18.
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Oncologist
; 27(3): 220-227, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274720
19.
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
Future Oncol
; 18(1): 35-45, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636627
20.
Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings.
Prostate
; 81(10): 657-666, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978244